Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma.

Jie MeiShao-Hua LiQi-Jiong LiXu-Qi SunLiang-He LuWen-Ping LinLie ZhengMin-Shan ChenMing ShiWei WeiRong-Ping Guo

Published in: Journal of hepatocellular carcinoma (2021)

In comparison to HAIC, HAICAP was associated with a better treatment response and survival benefits for patients with advanced HCC.

Keyphrases